DIABETIC FOOT ULCER CLINICAL RESEARCH TRIAL
Diabetic foot ulcers affect millions worldwide, often causing pain, infection, and a reduced quality of life. We are conducting a clinical research study to evaluate the safety and effectiveness of an investigational treatment that may provide new hope for individuals living with DFUs.
By participating, you’ll have the opportunity to contribute to important medical research, receive specialized care for your ulcer, and potentially help advance a breakthrough therapy for diabetic foot ulcers.
About the Study
This study seeks to understand whether Lanifibranor can help treat individuals with non-cirrhotic NASH and fibrosis, specifically those with Stage F2 or F3 fibrosis. If you qualify, this study offers:
-
Access to advanced medical care at no cost
-
Compensation for time and travel, up to $3,100
-
A chance to participate in cutting-edge research to improve liver health for yourself and others
What to Expect
As a participant, you’ll receive compassionate care and personalized monitoring by healthcare professionals committed to your safety and comfort. Here’s what you can expect:
-
Comprehensive Support: Regular check-ins, access to study information, and guidance from our dedicated team.
-
A Patient-Centered Experience: Every step of the study is designed to ensure a comfortable and supportive journey.
Valuable Contributions to Research: By participating, you’re helping researchers develop potential treatments for NASH-related fibrosis.
How to Get Started
If you or a loved one meets the eligibility criteria, this study could offer an opportunity to find relief and contribute to life-changing medical research.
-
Complete Our Interest Form: Fill out the form below to check if this study could be right for you.
Contact Haylee Kasuboski, our Patient Recruitment Specialist, by email at hkasuboski@biohrc.com or call toll-free at 803.764.2406.
When asked to do the study, I was worried it wouldn't work, but it was amazing. The people who work on the study were amazing also, and they made it so easy to understand. They made me feel like family when I was there. I would tell anybody who has endometriosis that the study is so worth it because I could live my life with no pain
— Tracy, Enrolled Patient
Did you know?
-
2-5% of the global population is affected by NASH, with millions of people suffering from this debilitating condition.
-
If left untreated, 20-30% of those with NASH will develop cirrhosis, leading to liver failure or the need for a transplant.
-
There are currently no FDA-approved treatments for NASH, making participation in this clinical trial a crucial step in advancing medical care for liver disease.
-
Join us in pioneering a solution. Your participation could help shape the future of NASH treatment, potentially improving lives for millions of people worldwide.
BioCentric Health Research Center: Leading the Way in Clinical Trials for Women’s Health
At BioCentric Health Research Center, we are committed to advancing medical knowledge and providing cutting-edge research opportunities for patients. With our experienced team of healthcare professionals and state-of-the-art research facility, we’ve been at the forefront of clinical trials since 2013. Our patient-centered approach ensures that your health and well-being are always our top priority.